Bright Future for XP Health After $17M Series A

Home » Blog » Bright Future for XP Health After $17M Series A

Rosenman ADAPT company XP Health, a vision care platform focusing on usability and accessibility, just came out of a successful Series A round of funding. XP Health and their investors hope to address a universal problem plaguing 93 million adults in the United States: risk of vision loss, and no doctor’s appointments to fix it.
From the press release:

XP Health, the company creating the first digital-first vision benefits platform, today announces a $17.1M Series A round led by HC9 VenturesValor Capital Group and ManchesterStory. Additional investors include Canvas Ventures, CameronVC, Core Innovation Capital, GSR Ventures, and Plug and Play, as well as high profile angels like Ken Goulet (former EVP Anthem), Kevin Hill (former regional CEO United Healthcare), Jeff Epstein (CFO of Oracle, partner at Bessemer Venture Partners) and Brett Rochkind (former managing partner General Atlantic). This expansion capital will bolster XP Health’s drive to reinvent how people experience vision benefits.

XP Health offers a high-quality, innovative vision care benefit that doubles the value of coverage while reducing costs by half for members. This recent fundraise follows a successful 2021 for the company, during which it raised $5.5 million and was named one of Fast Company’s Most Innovative Companies. Starting with just 30 clients last year, XP Health now services 1,500, including high-profile companies like Docusign, Chegg, Navistar, Sequoia Consulting, and strategic partners Guardian Life Insurance and The Health Benefit Alliance. All-in, XP Health covers more than 250,000 people.

Through its integrated supply chain, XP Health keeps costs low by removing the middlemen that add significant markups at several steps in the process. This business model has helped triple vision benefits coverage for employees while reducing their out-of-pocket costs by 80 percent, all while cutting employer eyewear claim costs by 40 percent. This model has also helped the company to grow their revenue by 9,300 percent since January 2021.

“This round of funding enables us to strengthen the platform’s functionality and provide a stellar consumer experience in the most affordable way to employers, insurance carriers, and employees,” said Antonio Moraes, Co-Founder, and CEO of XP Health and a former impact venture capital investor. “We have a game-changing offering for how people access and experience employee benefits – with an ultimate goal to positively impact hundreds of millions of lives through high-quality, accessible, and affordable health benefits.”

Vision coverage has remained static, complicated, expensive, and unsatisfying for decades. An estimated 93 million adults in the United States (about 25 percent of the population) are at high risk for serious vision loss, but only half visited an eye doctor in the past 12 months [1]. XP Health uses advanced technology to transform vision care into something people – whether they have 20/20 eyesight or need a prescription – are excited to use, and has a unique business model that lowers costs for all parties.

“The XP Health team is bringing some much-needed change to vision benefits. HC9 is excited to leverage our experience and network to help XP Health accelerate growth while improving eye health,” said Jon Gordon, General Partner of HC9 Ventures. “We know firsthand what it is like to operate and grow businesses that are driving health innovation, and XP Health is the perfect partner.”

“We believe that XP Health will fundamentally transform the future of vision benefits and are thrilled to contribute to their mission to innovate in the space,” said Michael Nicklas of Valor Capital Group. “XP Health is working hard towards expanding access to high quality vision care to millions of employees in the United States and we are proud to have backed the company since day one.”

“As an insuretech-focused investor, we know that quality benefit programs make a big difference in a company’s ability to attract and retain employees, which is especially important given the current state of the job market,” said David Miles of ManchesterStory. “XP Health is on a path to make vision care a ‘must have’ core employee benefit. Our confidence in XP Health’s founding team and their passion for the end-consumer made XP Health an investment opportunity we could not pass up.”

About XP Health
XP Health democratizes access to high-quality, delightful experiences in vision care that double coverage and reduce costs by half. It is the first modern vision platform focused on eye care and eyewear that can be used to enhance or replace existing vision plans, and uses artificial intelligence, augmented reality, and customer-centric design to create a stellar member experience. XP Health was named to the 2021 Fast Company list of the World’s Most Innovative Companies and over the past year has expanded from 30 to 1500+ customers, including Docusign, Palantir, Chegg, Sequoia Consulting, and strategic partner Guardian Life Insurance. To learn more visit

About HC9
HC9 is an early-stage venture capital firm purpose-built to provide industry-specific expertise to emerging healthcare software and services companies. HC9’s unparalleled, deeply-engaged investor community of leading executives, entrepreneurs, and investors collectively has thousands of years of experience in all facets of healthcare. We leverage the power of that experience to support the founders that are shaping the future of healthcare. For more information, please visit

About Valor Capital Group
Valor Capital Group is a global venture capital firm, focused on early-stage and growth equity investments. Currently, the Group has over $2 billion AUM, distributed across six funds. Valor pursues a cross-border strategy with a focus primarily in Brazil and throughout Latin America, as well as investing in international companies and helping them expand into the region. Since inception, the Firm has invested in over 100 companies, 20 of which are unicorns.

About ManchesterStory
ManchesterStory partners with world-class founders pursuing technological innovation in InsurTech and adjacent sectors. Focused on early-stage start-ups, ManchesterStory leads venture capital investments to fund growth while also connecting them with leading financial services companies across North America and beyond.